SYMMETRYRX Trademark

Trademark Overview


On Tuesday, June 14, 2022, a trademark application was filed for SYMMETRYRX with the United States Patent and Trademark Office. The USPTO has given the SYMMETRYRX trademark a serial number of 97456625. The federal status of this trademark filing is REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED as of Monday, January 22, 2024. This trademark is owned by SymmetryRx LLC. The SYMMETRYRX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Platform as a service (PAAS) featuring computer software platforms for enabling sponsoring pharmaceutical manufacturers to communicate with prospective customer patients about prescription medications; Platform as a service (PAAS) featuring computer software platforms for administering and managing patient support services, namely, computer software platforms for providing patient information and resources for medications, conditions, or other healthcare issues; Platform as a service (PAAS) featuring computer software platforms for managing electronic prescription work flow and electronic healthcare records, namely, computer software platforms for requesting and fulfilling online orders for pharmaceutical samples, and for viewing, editing, and storing electronic healthcare records; Platform as a service (PAAS) featuring computer software platforms for operating a prescription eligibility program for patients and prescribers, namely, computer software platforms for qualifying patients f...
symmetryrx

General Information


Serial Number97456625
Word MarkSYMMETRYRX
Filing DateTuesday, June 14, 2022
Status654 - REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED
Status DateMonday, January 22, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkSYMMETRY RX
Goods and ServicesPlatform as a service (PAAS) featuring computer software platforms for enabling sponsoring pharmaceutical manufacturers to communicate with prospective customer patients about prescription medications; Platform as a service (PAAS) featuring computer software platforms for administering and managing patient support services, namely, computer software platforms for providing patient information and resources for medications, conditions, or other healthcare issues; Platform as a service (PAAS) featuring computer software platforms for managing electronic prescription work flow and electronic healthcare records, namely, computer software platforms for requesting and fulfilling online orders for pharmaceutical samples, and for viewing, editing, and storing electronic healthcare records; Platform as a service (PAAS) featuring computer software platforms for operating a prescription eligibility program for patients and prescribers, namely, computer software platforms for qualifying patients for discounts for prescriptions; Platform as a service (PAAS) featuring computer software platforms for communicating offers for prescriptions to prospective customer patients; Platform as a service (PAAS) featuring computer software platforms for managing patient consents, namely, computer software platforms for obtaining and storing patient consents; Platform as a service (PAAS) featuring computer software platforms for recording patient consents; Platform as a service (PAAS) featuring computer software platforms for managing prescription routing for fulfillment and delivery of prescriptions to patients; Platform as a service (PAAS) featuring computer software platforms for providing patients with medication information, educational materials, and adherence support services sponsored by the manufacturer from the program pharmacy; Platform as a service (PAAS) featuring computer software platforms for analyzing and optimizing patient selection and prescription program management, namely, computer software platforms for matching patients with potential discount programs; Platform as a service (PAAS) featuring computer software platforms for providing data security in accordance with applicable regulations in the field of prescription medications

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, June 27, 2022
Primary Code042
First Use Anywhere DateFriday, November 30, 2018
First Use In Commerce DateFriday, November 30, 2018

Trademark Owner History


Party NameSymmetryRx LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressRADNOR, PA 19087

Trademark Events


Event DateEvent Description
Monday, January 22, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, June 28, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, June 28, 2023LETTER OF SUSPENSION E-MAILED
Wednesday, June 28, 2023SUSPENSION LETTER WRITTEN
Tuesday, April 11, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 10, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 10, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 28, 2022ASSIGNED TO EXAMINER
Sunday, October 9, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, October 9, 2022NON-FINAL ACTION E-MAILED
Sunday, October 9, 2022NON-FINAL ACTION WRITTEN
Sunday, October 2, 2022ASSIGNED TO EXAMINER
Monday, June 27, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 17, 2022NEW APPLICATION ENTERED